Appointment of Mr. Yogesh Supekar DIN: 11344916 as Non Executive Non Independent Director.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Asston Pharmaceuticals' board, meeting on 16 October 2025, appointed Mr. Yogesh Supekar (DIN: 11344916) as Additional Non-Executive Non-Independent Director and Mr. Rishi Upadhaya as Company Secretary and Compliance Officer. M/s Yash A. Jain & Associates was appointed as internal auditor for FY 2025-26. The board also approved taking unsecured, interest-free loans from directors up to Rs. 3 crore and a secured loan from HDFC Bank up to Rs. 2.70 crore for purchasing commercial space. The newly appointed director and CS are not related to existing directors and are not debarred by SEBI or any authority.
Multiple governance-related changes in one board meeting, including fresh director and KMP appointments. The Rs. 5.7 crore combined borrowing (Rs. 3 crore from directors interest-free plus Rs. 2.70 crore bank loan) signals expansion or real estate acquisition, which shareholders should track for further clarity.